Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company is engaged in the research, development, manufacturing, and marketing of generic pharmaceutical formulations.
Torrent Pharmaceuticals Ltd, is a listed public company incorporated on 15 July, 1972. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 235.00 cr and the total paid-up capital is INR 169.22 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
14.13%
17.35%
6.05%
1.74%
36.55%
15.42%
0.49
0.88
-0.75
0.67
1.52
0.18
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(53)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
IDBI Trusteeship Services Limited
No. of Loans: 4
Total Amount : 3,100.0 cr
HDFC Bank Limited
No. of Loans: 3
Total Amount : 1,100.0 cr
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 3
Total Amount : 595.0 cr
Union Bank of India
No. of Loans: 1
Total Amount : 550.0 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 300.0 cr
CitiBank N.A.
No. of Loans: 1
Total Amount : 50.2 cr
BNP Paribas
No. of Loans: 1
Total Amount : 50.0 cr
Standard Chartered Bank
No. of Loans: 1
Total Amount : 44.8 cr
STATE BANK OF INIDA
No. of Loans: 1
Total Amount : 0.7 cr
Gujarat Industrial Investment Corporation Limited
No. of Loans: 1
Total Amount : 0.6 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Nikhil Khattau Nirvan | 00017880 | 1 years |
| Director | Manish Mahendra Choksi | 00026496 | 2 years |
| Managing Director | Samir Uttamlal Mehta
Shareholder
|
00061903 | 14 years |
| Director | Ameera Sushil Shah
Shareholder
|
00208095 | 6 years |
| Director | Jinal Sudhirbhai Mehta | 02685284 | 1 years |
| Director | Nayantara Bali | 03570657 | 6 years |
| Whole-time Director | Aman Samir Mehta
Shareholder
|
08174906 | 2 years |
| CFO | Sudhir Menon
Shareholder
|
<HIDDEN> | 6 years |
| Director | Maurice Antoine Rene Chagnaud | 09592878 | 3 years |
| CS | Chintan Maheshkumar Trivedi | <HIDDEN> | 2 years |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Zao Torrent Pharma | Russia | - | - |
| Torrent Do Brasil Ltda. | Brazil | - | - |
| Torrent Pharma Gmbh | Germany | - | - |
| Torrent Pharma Inc. | Usa | - | - |
| Torrent Pharma Philippines, Inc. | Philippines | - | - |
| Laboratorios Torrent, S.A. De C.V. | Mexico | - | - |
| Torrent Australasia Pty Ltd | Australia | - | - |
| Torrent Pharma (Thailand) Co., Ltd. | Thailand | - | - |
| Torrent Pharma (UK) Ltd | United Kingdom | - | - |
| Laboratories Torrent (Malaysia) SDN.BHD. | Malaysia | - | - |
| Heumann Pharma Gmbh & Co. Generica KG | Germany | - | - |
| Heunet Pharma Gmbh | Germany | - | - |
| TPL (Malta) Limited | Malta | - | - |
| Torrent Pharma(Malta) Ltd | Malta | - | - |
| Curatio Inc., Philippines | Philippines | - | - |
| Curatio International Lanka (PVT) Ltd | Srilanka | - | - |
The incorporation date of TORRENT PHARMACEUTICALS LTD is 15 July, 1972
The authorized share capital of TORRENT PHARMACEUTICALS LTD is INR ₹ 235.0 Cr.
The paid-up capital of TORRENT PHARMACEUTICALS LTD is INR ₹ 169.2 Cr.
The registered address of TORRENT PHARMACEUTICALS LTD is TORRENT HOUSEOFF ASHRAM ROAD NAVARANGPURA 9 NA AHMEDABAD Gujarat - 000000
The CIN number of TORRENT PHARMACEUTICALS LTD is L24230GJ1972PLC002126.
Expand
Delete
Collapse
See
details
